3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
43
Completed
43
Recruiting
20
Not yet recruiting
9
Enrolling by invitation
3
Active not recruiting
3
Terminated
2
Withdrawn
1
Suspended
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Colorectal Neoplasms
158
Pancreatic Neoplasms
148
Carcinoma, Hepatocellular
127
Colonic Neoplasms
79
Stomach Neoplasms
58
Rectal Neoplasms
58
Liver Neoplasms
47
Esophageal Neoplasms
46
Breast Neoplasms
40
Neoplasms
36
Neoplasm Metastasis
35
Cholangiocarcinoma
32
Lung Neoplasms
23
Gastrointestinal Neoplasms
20
Ovarian Neoplasms
17
Biliary Tract Neoplasms
15
Carcinoma, Non-Small-Cell Lung
14
Esophageal Squamous Cell Carcinoma
13
Uterine Cervical Neoplasms
11
Gallbladder Neoplasms
10
Adenocarcinoma
10
Sarcoma
9
Carcinoma, Renal Cell
9
Adenocarcinoma Of Esophagus
9
Urinary Bladder Neoplasms
8
Recurrence
8
Bile Duct Neoplasms
8
Prostatic Neoplasms
7
Gastrointestinal Stromal Tumors
7
Colonic Polyps
7
Interventions
Sodium Chloride
1
Saline Solution
1
Neomycin
1
Metronidazole
1
Ciprofloxacin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Withdrawn
×
Anastomotic Leak
×
Gastrointestinal
×
Clear all
NCT02682485
2023-04-26
SES-DTA
University of Chicago
Phase 2
Withdrawn